Skip to main content

MoneyWorks4Me

Vivanza Biosciences informs about non-applicability of statement of deviation or variation

11 Apr 2024 Evaluate

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding submission of Statement of Deviation or Variation from proceeds of public issue/rights issue/preferential issue, Qualified Institutions Placement (QIP) etc., Vivanza Biosciences has confirmed that the Company has not raised any further fund by the means of Public Issue, Rights Issue, or Preferential Issue etc. Hence, the Statement of deviation(s) or variation(s) is not being provided as it is not applicable to the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 334.30
Adani Enterprises 2694.30
Amrapali Industries 32.05
Maxgrow India 164.55
Rashi Peripheral 638.05
View more..